UCB PHARMA-PROD.FARMACEUTICOS, LDA secures contract for Antineoplastic and immunomodulating agents - 2023/0671 - CERTOLIZUMAB PEGOL [200 MG/ 1 ML; CANETA]

Portugal, Aug. 13 -- Portugal based UCB PHARMA-PROD.FARMACEUTICOS, LDA has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for Antineoplastic and immunomodulating agents - 2023/0671 - CERTOLIZUMAB PEGOL [200 MG/ 1 ML; CANETA]. The value of the contract is worth 30268200 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....